{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:46:44Z","timestamp":1790171204297,"version":"4.1.0"},"reference-count":24,"publisher":"Rockefeller University Press","issue":"5","license":[{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T00:00:00Z","timestamp":1572739200000},"content-version":"vor","delay-in-days":206,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA169416"],"award-info":[{"award-number":["R01-CA169416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Feldstein Foundation"},{"name":"Starr Cancer Consortium"},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ram\u00f3n y Cajal Program"},{"name":"\"La Caixa\" Foundation","award":["100010434"],"award-info":[{"award-number":["100010434"]}]},{"name":"\"La Caixa\" Foundation","award":["LCF\/BQ\/ES17\/11600007"],"award-info":[{"award-number":["LCF\/BQ\/ES17\/11600007"]}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n de Investigaci\u00f3n Oncol\u00f3gica"},{"name":"Ministerio de Econom\u00eda y Competitividad-Red de Excelencia en Investigaci\u00f3n e Innovaci\u00f3n en Exosomas"},{"DOI":"10.13039\/100008054","name":"Ram\u00f3n Areces Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Atresmedia-Fundaci\u00f3n AXA"},{"DOI":"10.13039\/100012818","name":"Comunidad Aut\u00f3noma de Madrid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5,6]]},"abstract":"<jats:p>Liquid biopsies from cancer patients have the potential to improve diagnosis and prognosis. The assessment of surrogate markers of tumor progression in circulating extracellular vesicles could be a powerful non-invasive approach in this setting. We have characterized extracellular vesicles purified from the lymphatic drainage also known as exudative seroma (ES) of stage III melanoma patients obtained after lymphadenectomy. Proteomic analysis showed that seroma-derived exosomes are enriched in proteins resembling melanoma progression. In addition, we found that the BRAFV600E mutation can be detected in ES-derived extracellular vesicles and its detection correlated with patients at risk of relapse.<\/jats:p>","DOI":"10.1084\/jem.20181522","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T18:50:00Z","timestamp":1555008600000},"page":"1061-1070","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":129,"title":["Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and <i>BRAF<\/i>\n                  <i>V600E<\/i> mutation"],"prefix":"10.1084","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-0245","authenticated-orcid":false,"given":"Susana","family":"Garc\u00eda-Silva","sequence":"first","affiliation":[{"name":"Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Benito-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Children's Cancer and Blood Foundation Laboratories, Department of Pediatrics, Weill Cornell Medicine, New York, NY 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"S\u00e1nchez-Redondo","sequence":"additional","affiliation":[{"name":"Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-5107","authenticated-orcid":false,"given":"Alberto","family":"Hern\u00e1ndez-Barranco","sequence":"additional","affiliation":[{"name":"Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Xim\u00e9nez-Emb\u00fan","sequence":"additional","affiliation":[{"name":"Proteomics Unit\u2013ProteoRed-Instituto de Salud Carlos III, Spanish National Cancer Research Center, Madrid, Spain 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nogu\u00e9s","sequence":"additional","affiliation":[{"name":"Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina S.","family":"Mazariegos","sequence":"additional","affiliation":[{"name":"Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Brinkmann","sequence":"additional","affiliation":[{"name":"Exosome Diagnostics, GmbH, Martinsried, Germany 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Amor L\u00f3pez","sequence":"additional","affiliation":[{"name":"Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Meyer","sequence":"additional","affiliation":[{"name":"Exosome Diagnostics, GmbH, Martinsried, Germany 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Electron Microscopy Unit, Spanish National Cancer Research Center, Madrid, Spain 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Electron Microscopy Unit, Spanish National Cancer Research Center, Madrid, Spain 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasminka","family":"Boskovic","sequence":"additional","affiliation":[{"name":"Electron Microscopy Unit, Spanish National Cancer Research Center, Madrid, Spain 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Let\u00f3n","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Group, Spanish National Cancer Research Center, Madrid, Spain 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Montero","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Group, Spanish National Cancer Research Center, Madrid, Spain 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Group, Spanish National Cancer Research Center, Madrid, Spain 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Santambrogio","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, Albert Einstein College of Medicine, New York, NY 12"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sue Brady","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY 13"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szumera-Cie\u0107kiewicz","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie Institute\u2013Oncology Center, Department of Pathology and Laboratory Medicine, Warsaw, Poland 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Kalinowska","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie Institute\u2013Oncology Center, Department of Soft Tissue\/Bone Sarcoma and Melanoma, Warsaw, Poland 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Skog","sequence":"additional","affiliation":[{"name":"Exosome Diagnostics, Inc., Waltham, MA 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Noerholm","sequence":"additional","affiliation":[{"name":"Exosome Diagnostics, GmbH, Martinsried, Germany 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Proteomics Unit\u2013ProteoRed-Instituto de Salud Carlos III, Spanish National Cancer Research Center, Madrid, Spain 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo L.","family":"Ortiz-Romero","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical school, Universidad Complutense de Madrid, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-9369","authenticated-orcid":false,"given":"Yolanda","family":"Ruano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical school, Universidad Complutense de Madrid, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Rodr\u00edguez-Peralto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical school, Universidad Complutense de Madrid, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie Institute\u2013Oncology Center, Department of Soft Tissue\/Bone Sarcoma and Melanoma, Warsaw, Poland 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4256-3413","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Peinado","sequence":"additional","affiliation":[{"name":"Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2019,4,11]]},"reference":[{"key":"2023072604422194100_bib1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/annonc\/mdx542","article-title":"High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients","volume":"28","author":"Allenson","year":"2017","journal-title":"Ann. Oncol."},{"key":"2023072604422194100_bib2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis data portal for visualization and analysis of brain tumor expression datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro-oncol."},{"key":"2023072604422194100_bib3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181618","article-title":"Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients","author":"Broggi","year":"2019","journal-title":"J. Exp. Med."},{"key":"2023072604422194100_bib4","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1083\/jcb.201612051","article-title":"Lymphatic exosomes promote dendritic cell migration along guidance cues","volume":"217","author":"Brown","year":"2018","journal-title":"J. Cell Biol."},{"key":"2023072604422194100_bib5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.canlet.2017.06.030","article-title":"Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma","volume":"404","author":"Calapre","year":"2017","journal-title":"Cancer Lett."},{"key":"2023072604422194100_bib6","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1158\/1078-0432.CCR-17-3369","article-title":"Exosome-based detection of EGFR T790M in plasma from non-small cell lung cancer patients","volume":"24","author":"Castellanos-Rizaldos","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"2023072604422194100_bib7","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/neuonc\/nox085","article-title":"Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients","volume":"19","author":"Figueroa","year":"2017","journal-title":"Neuro-oncol."},{"key":"2023072604422194100_bib8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/intimm\/dxv012","article-title":"Lymph formation, composition and circulation: a proteomics perspective","volume":"27","author":"Hansen","year":"2015","journal-title":"Int. Immunol."},{"key":"2023072604422194100_bib9","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1158\/0008-5472.CAN-10-4455","article-title":"Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis","volume":"71","author":"Hood","year":"2011","journal-title":"Cancer Res."},{"key":"2023072604422194100_bib10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature."},{"key":"2023072604422194100_bib11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1172\/JCI71606","article-title":"Mechanisms of lymphatic metastasis","volume":"124","author":"Karaman","year":"2014","journal-title":"J. Clin. Invest."},{"key":"2023072604422194100_bib12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2023072604422194100_bib13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/pcmr.12290","article-title":"Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients","volume":"27","author":"Mactier","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"2023072604422194100_bib14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1158\/1078-0432.CCR-17-2007","article-title":"Liquid biopsies using plasma exosomal nucleic acids and plasma cell-free DNA compared with clinical outcomes of patients with advanced cancers","volume":"24","author":"M\u00f6hrmann","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"2023072604422194100_bib15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"2023072604422194100_bib16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer."},{"key":"2023072604422194100_bib17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.aaf1328","article-title":"SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions","volume":"352","author":"Pucci","year":"2016","journal-title":"Science."},{"key":"2023072604422194100_bib18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/CMR.0b013e328307bf3f","article-title":"Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection","volume":"18","author":"Rutkowski","year":"2008","journal-title":"Melanoma Res."},{"key":"2023072604422194100_bib19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1158\/1078-0432.CCR-15-0321","article-title":"Correlation of BRAF mutation status in circulating-free DNA and tumor and association with clinical outcome across four BRAFi and MEKi clinical trials","volume":"22","author":"Santiago-Walker","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"2023072604422194100_bib20","doi-asserted-by":"publisher","first-page":"18374","DOI":"10.3402\/jev.v1i0.18374","article-title":"ExoCarta as a resource for exosomal research","volume":"1","author":"Simpson","year":"2012","journal-title":"J. Extracell. Vesicles."},{"key":"2023072604422194100_bib21","doi-asserted-by":"publisher","first-page":"24436","DOI":"10.1038\/srep24436","article-title":"Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node","volume":"6","author":"Srinivasan","year":"2016","journal-title":"Sci. Rep."},{"key":"2023072604422194100_bib22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/cr.2014.44","article-title":"Double-stranded DNA in exosomes: a novel biomarker in cancer detection","volume":"24","author":"Thakur","year":"2014","journal-title":"Cell Res."},{"key":"2023072604422194100_bib23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1245\/ASO.2004.03.023","article-title":"Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay","volume":"11","author":"W\u0142odzimierz","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"2023072604422194100_bib24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/15384047.2017.1281499","article-title":"Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol. Ther."}],"updated-by":[{"DOI":"10.1084\/jem.2018152204162019c","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000}}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/216\/5\/1061\/1761262\/jem_20181522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/216\/5\/1061\/1761262\/jem_20181522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T04:45:32Z","timestamp":1690346732000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/216\/5\/1061\/121010\/Use-of-extracellular-vesicles-from-lymphatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,6]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20181522","relation":{"correction":[{"id-type":"doi","id":"10.1084\/jem.2018152204162019c","asserted-by":"object"}]},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,11]]}}}